Geotrif Tablets 40mg (Afatinib Maleate) from Nippon Boehringer Ingelheim, YJ code 4291030F3023 (40mg 1 tablet), is a kinase inhibitor indicated for the first-line treatment of metastatic non-small cell lung cancer with certain EGFR mutations, and for metastatic squamous NSCLC progressing after platinum-based chemotherapy.
Geotrif Tablets 40mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
